Table 3.
Mean percentages of the immune cells in peripheral blood of normal subjects and the COVID-19 patients.
Normal subjects (n = 20) | Asymptomatic recovered donors (n = 20) | Non-ICU hospitalized patients (n = 30) | ICU hospitalized patients (n = 30) | ||
---|---|---|---|---|---|
Lymphocytes | Percentage | 33.85 ± 4.68 | 32.1 ± 4.19 | 31.2 ± 3.8 | 24.6 ± 2.9 |
Absolute count (×10−3/ml) | 2.6 (0.9–3.1) | 2.45 (0.85–3) | 2.3 (0.8–2.4) | 0.91 (0.3–1.9) | |
Monocytes | Percentage | 3.26 ± 1.22 | 4.09 ± 1.45 | 4.13 ± 1.3 | 4.82 ± 1.57 |
Absolute count (×10−3/ml | 0.45 (0.13–0.68) | 0.51 (0.12–0.7) | 0.56 (0.12–0.72) | 0.6 (0.13–0.73) | |
Granulocytes | Percentage | 59.15 ± 10.18 | 58.4 ± 11.35 | 63.13 ± 10.23 | 69.07 ± 9.68 |
Absolute count (×10−3/ml | 6.7 (1.6–8.7) | 6.8 (1.7–8.5) | 7.1 (1.57–8.45) | 7.4 (1.62–8.53) | |
Th1 (%) | 22.95 ± 4.91 | 23.96 ± 5.36 | 25.6 ± 3.72 | 27.72 ± 3.33 | |
Th2 (%) | 5.25 ± 1.05 | 4.91 ± 1.88 | 3.76 ± 1.36 | 6.31 ± 0.82 | |
Th1/Th2 (%) | 4.64 ± 1.14 | 4.94 ± 0.83 | 5.66 ± 1.02 | 4.25 ± 0.94 | |
Treg (%) | 6.32 ± 1.78 | 6.84 ± 1.47 | 5.53 ± 1.38 | 4.85 ± 1.3 | |
Th17 (%) | 3.7 ± 1.29 | 3.11 ± 1.06 | 5.26 ± 1.72 | 5.51 ± 1.51 | |
Th17/Treg (%) | 0.47 ± 0.15 | 0.41 ± 0.08 | 0.96 ± 0.12 | 1.1 ± 0.15 | |
CD4+PD-1+ (%) | 4.82 ± 0.74 | 3.53 ± 0.85 | 4.62 ± 1.14 | 4.94 ± 1.02 | |
CD8+PD-1+ (%) | 2.82 ± 0.65 | 2.91 ± 0.79 | 3.28 ± 0.64 | 3.6 ± 0.71 | |
CD4+LAG-3+ (%) | 2.22 ± 0.72 | 2.3 ± 0.61 | 2.88 ± 0.74 | 3.12 ± 0.84 | |
CD8+LAG-3+ (%) | 2.66 ± 0.61 | 2.8 ± 0.79 | 3.03 ± 0.88 | 3.2 ± 0.81 |